Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gregory R Pond

Showing results (111-120 of 255) with videos related to

Pageof 26
Sort By:
Blood Cancer Journal|January 28, 2022
Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based studyHira Mian, Rinku Sutradhar, Gregory R Pond, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2021
Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported OutcomesMohammed S Ebraheem, Hsien Seow, Amaris K Balitsky, et al.
Cancer|March 3, 2011
The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.
American Journal of Clinical Oncology|April 1, 2008
Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret HospitalJeff Rothenstein, Sean P Cleary, Gregory R Pond, et al.
Leukemia|April 11, 2021
External validation of the FIRST trial's simplified frailty score in a population-based cohortHira S Mian, Smith Giri, Tanya M Wildes, et al.
Urologic Oncology|October 5, 2010
Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.
European Urology|October 27, 2015
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving DocetaxelGuru Sonpavde, Gregory R Pond, Arnoud J Templeton, et al.
Breast Cancer Research and Treatment|December 28, 2014
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implicationsKatarzyna J Jerzak, Jessica Cockburn, Gregory R Pond, et al.
Nursing Leadership (Toronto, Ont.)|August 8, 2023
Differentiating Specialized and Advanced Nursing Roles: The Pathway to Role OptimizationKrista Jokiniemi, Denise Bryant-Lukosius, Josette Roussel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Measured and estimated GFR in healthy potential kidney donorsAndrew D Rule, Hiie M Gussak, Gregory R Pond, et al.
Pageof 26

Showing results (111-120 of 255) with videos related to

Sort By:
Pageof 26
Blood Cancer Journal|January 28, 2022
Patient-reported outcome measures are associated with health care utilization in patients with transplant ineligible multiple myeloma: a population-based studyHira Mian, Rinku Sutradhar, Gregory R Pond, et al.
Clinical Lymphoma, Myeloma & Leukemia|June 8, 2021
Trajectory of Symptoms in Patients Undergoing Autologous Stem Cell Transplant for Multiple Myeloma: A Population-Based Cohort Study of Patient-Reported OutcomesMohammed S Ebraheem, Hsien Seow, Amaris K Balitsky, et al.
Cancer|March 3, 2011
The association between radiographic response and overall survival in men with metastatic castration-resistant prostate cancer receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.
American Journal of Clinical Oncology|April 1, 2008
Neuroendocrine tumors of the gastrointestinal tract: a decade of experience at the Princess Margaret HospitalJeff Rothenstein, Sean P Cleary, Gregory R Pond, et al.
Leukemia|April 11, 2021
External validation of the FIRST trial's simplified frailty score in a population-based cohortHira S Mian, Smith Giri, Tanya M Wildes, et al.
Urologic Oncology|October 5, 2010
Serum alkaline phosphatase changes predict survival independent of PSA changes in men with castration-resistant prostate cancer and bone metastasis receiving chemotherapyGuru Sonpavde, Gregory R Pond, William R Berry, et al.
European Urology|October 27, 2015
Association Between RECIST Changes and Survival in Patients with Metastatic Castration-resistant Prostate Cancer Receiving DocetaxelGuru Sonpavde, Gregory R Pond, Arnoud J Templeton, et al.
Breast Cancer Research and Treatment|December 28, 2014
Thyroid hormone receptor α in breast cancer: prognostic and therapeutic implicationsKatarzyna J Jerzak, Jessica Cockburn, Gregory R Pond, et al.
Nursing Leadership (Toronto, Ont.)|August 8, 2023
Differentiating Specialized and Advanced Nursing Roles: The Pathway to Role OptimizationKrista Jokiniemi, Denise Bryant-Lukosius, Josette Roussel, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|January 9, 2004
Measured and estimated GFR in healthy potential kidney donorsAndrew D Rule, Hiie M Gussak, Gregory R Pond, et al.
Pageof 26